Emvision Medical Devices Ltd (EMV) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.301x

Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has a cash flow conversion efficiency ratio of -0.301x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.94 Million ≈ $-4.20 Million USD) by net assets (AU$19.74 Million ≈ $13.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Emvision Medical Devices Ltd worth for the company's overall valuation and market capitalisation.

Emvision Medical Devices Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Emvision Medical Devices Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Emvision Medical Devices Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Emvision Medical Devices Ltd ranked by their cash flow conversion efficiency. See Emvision Medical Devices Ltd cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Chaintech Technology Corp
TW:2425
-0.029x
Brouwerij Handelsmaatschappij NV
BR:COBH
0.120x
Lippo General Insurance Tbk
JK:LPGI
0.125x
We&Win Diversification Co Ltd
TWO:4113
-0.006x
Digimarc Corporation
NASDAQ:DMRC
-0.027x
FSA Group Ltd
AU:FSA
0.105x
Global Fashion Group SA
XETRA:GFG
0.048x
Libstar Holdings Ltd
JSE:LBR
0.087x

Annual Cash Flow Conversion Efficiency for Emvision Medical Devices Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025. View Emvision Medical Devices Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$9.28 Million
≈ $6.57 Million
AU$-7.84 Million
≈ $-5.54 Million
-0.844x -160.85%
2024-06-30 AU$18.52 Million
≈ $13.10 Million
AU$-5.99 Million
≈ $-4.24 Million
-0.324x -298.43%
2023-06-30 AU$5.12 Million
≈ $3.62 Million
AU$834.15K
≈ $590.22K
0.163x +130.53%
2022-06-30 AU$7.08 Million
≈ $5.01 Million
AU$-3.78 Million
≈ $-2.68 Million
-0.534x -19.47%
2021-06-30 AU$10.05 Million
≈ $7.11 Million
AU$-4.49 Million
≈ $-3.18 Million
-0.447x +24.14%
2020-06-30 AU$5.52 Million
≈ $3.91 Million
AU$-3.26 Million
≈ $-2.30 Million
-0.589x -22.46%
2019-06-30 AU$4.60 Million
≈ $3.26 Million
AU$-2.22 Million
≈ $-1.57 Million
-0.481x +9.42%
2018-06-30 AU$1.28 Million
≈ $905.05K
AU$-679.59K
≈ $-480.85K
-0.531x --

About Emvision Medical Devices Ltd

AU:EMV Australia Medical Devices
Market Cap
$112.45 Million
AU$158.93 Million AUD
Market Cap Rank
#18848 Global
#596 in Australia
Share Price
AU$1.71
Change (1 day)
+3.95%
52-Week Range
AU$1.48 - AU$1.96
All Time High
AU$4.13
About

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more